Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind trial of ketoprofen patches for knee osteoarthritis pain
CTR20261536Phase 3Active
- Sponsor
- Sunshine Novo
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketoprofen in knee osteoarthritis (OA), osteoarthritis (OA), sponsored by Sunshine Novo. Started May 2026; status: active.
02
Drugs
ketoprofen
03
Conditions
knee osteoarthritis (OA)osteoarthritis (OA)
Beyond the preview
Go deeper on CTR20261536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261536.